• Fri frakt över 249 kr
  • •
  • Snabba leveranser
  • •
  • Billiga böcker
Kundservice

Du är på sajten för privatpersoner.

Företag, bibliotek eller offentlig verksamhet?

Du handlar på classic.bokus.com, där alla dina funktioner finns intakta.
Till classic.bokus.com
Bokus logotyp. Gå till startsidan.
  • Erbjudanden
  • Nyheter
  • Student
  • Topplistor
  • Barn & ungdom
  • Bokus Play
  • E-böcker
  • Pocketböcker
  • Spel & pussel

10% rabatt på allt med kod: NYSTART10 →

Sidfot

Mina sidor

    Hjälp

    • Kundservice
    • Vanliga frågor och svar
    • Frakt och leverans
    • Retur vid ångerrätt
    • Reklamera vara
    • Betalning
    • Köpvillkor
    • Allmänna villkor
    • Information om webbplatsens tillgänglighet

    Om Bokus

    • Om oss
    • Pressrum
    • För studenter
    • För företag
    • För bibliotek och offentlig verksamhet
    • För leverantörer
    • Hållbarhet

    Populärt

    • Aktuella erbjudanden
    • Presentkort
    • Studentlitteratur
    • Nya böcker
    • Topplistor
    • Signerade böcker
    • Engelska böcker

    Inspiration

    • Boktips
    • BookTok
    • Populära bokserier
    • Barnbokskaraktärer
    • Populära författare
    Logotyp för Bokus
    Följ oss på Facebook (extern länk)Följ oss på Instagram (extern länk)Följ oss på YouTube (extern länk)Följ oss på TikTok (extern länk)
    bokus @ CookiesAnpassa cookiesIntegritetspolicyKöpvillkor
    Till Citymail hemsida (extern länk)Till Budbee hemsida (extern länk)Till Postnord hemsida (extern länk)Till Schenker hemsida (extern länk)Till Early Bird hemsida (extern länk)Till Walleys hemsida (extern länk)
    1. Medicin
    2. Medicin: icke kliniska discipliner
    3. Fysiologi
    • Nyhet

    Smart Biosensing Technologies for Early Detection of Metabolic Disorders

    AvKanwal Rehman,Muhammad Sajid Hamid Akash

    Häftad, Engelska, 2026

    2 029 kr

    Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

    Beskrivning

    Smart Biosensing Technologies for Early Detection of Metabolic Disorders gives a clear overview of the latest biosensor tools that help detect and monitor metabolic diseases like diabetes, obesity, and insulin resistance early. It explains how these sensors work using basic science and shows new wearable, non-invasive, and easy-to-use devices. This book is useful for researchers, doctors, and professionals working in healthcare technology. This book connects research from different fields to help solve real problems in making and using biosensors. It includes examples of how these sensors are used, new markers for disease detection, and how AI and digital health can improve care. Readers will learn how to develop better diagnostic tools and improve treatment for metabolic diseases.

    • Provides comprehensive coverage of smart biosensing technologies for MDs, emphasizing biophysical mechanisms and disease-specific applications
    • Includes translational case studies and practical guidance on clinical validation, reliability assessment, regulatory challenges, and commercialization pathways
    • Highlights emerging biomarkers, multiomic approaches, AI-enabled biosensors, and digital health integration for personalized metabolic healthcare
    • Bridges multidisciplinary perspectives from biomedical sciences, engineering, data science, and pharmaceutical innovation to support real-world clinical impact

    Produktinformation

    • Utgivningsdatum:2026-08-13
    • Mått:216 x 276 x undefined mm
    • Vikt:450 g
    • Format:Häftad
    • Språk:Engelska
    • Antal sidor:760
    • Förlag:Elsevier Science
    • ISBN:9780443459115

    Utforska kategorier

    • Fysiologi inom Medicin
    • Endokrinologi inom Medicin
    • Tillämpad fysik inom Naturvetenskap och teknik

    Mer om författaren

    Dr. Kanwal Rehman is working as an Associate Professor at the Department of Pharmacy in The Women University, Multan, Pakistan. Dr. Rehman received her PhD in Pharmacology from Zhejiang University, China. She nurturesa keen interest in the pathogenesis of metabolic disorders and new therapeutic modalities for its treatment. Currently, sheis focusing on the investigation of the role of pharmacogenomics based upon gene polymorphism on various molecular andmetabolic pathways that are involved in mitogenic disorders and treatment strategies, like natural biogenic compounds against different risk factors of metabolic disorders, including pancreatitis, cardiometabolic disorders, and hormonal imbalance. Dr. Rehman has also been awarded the Research Productivity Award by the Pakistan Council for Science and Technology, Pakistan; the PAS Gold Medal from the Pakistan Academy of Sciences; and the A.R. Shakoori Gold Medal from the Zoological Society of Pakistan. Dr. Akash is currently working as an Associate Professor at the Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan. He got his PhD degree in Pharmaceutical Analysis from Zhejiang University, China. Currently, he is focusing on investigating the effect of endocrine disruptingchemicals on various molecular and metabolic pathways that are involved in metabolic disorders and their treatment strategies. His research work is cutting-edge and worthy of extension in developing countries, like Pakistan, where it can be most beneficial and cost-effective, especially for diabetic patients. Based on his significant scientific contributions inthe field of Pharmaceutical Sciences, he has been awarded “Research Productivity Awards” from the Pakistan Council for Science and Technology, the PAS Gold Medal from the Pakistan Academy of Sciences, and the A.R. Shakoori Gold Medal from the Zoological Society of Pakistan.

    Innehållsförteckning

    • Section I: Foundations of biosensing and metabolic disorders1. Detecting the preclinical window in metabolic disorders: Biomarkers, biosensors, diagnostic challenges, and translational opportunities2. Multi-omic biomarkers and biosensors for metabolic disorders: Discovery to clinical translation3. Metabolic biosensing technologies: Biophysical foundations, transduction strategies, and clinical translationSection II: Emerging biosensing platforms for biomarker detection4. Nanomaterials for metabolic biosensing: Interfacial biophysics, analytical performance, and clinical translation5. Microfluidic and paper-based biosensing technologies for metabolic disorders: From sample processing to clinical translation6. Wearable optical and electrochemical biosensors for continuous metabolic monitoring: Principles, system integration, and clinical translationSection III: Smart and intelligent biosensing approaches7. Artificial intelligence and machine learning for metabolic biosensors: From data analytics to clinical deployment8. Cloud—edge architectures for connected metabolic care: IoMT integration, interoperability, analytics, and lifecycle management9. Continuous wearable and implantable biosensors for metabolic disorders: From biosensing technologies to clinical translationSection IV: Applications in early detection of specific metabolic disorders10. Smart biosensing technologies for diabetes mellitus: From biomarker discovery and sensor design to clinical validation and real-world deployment11. Multimodal biosensing and continuous phenotyping for obesity and metabolic syndrome: Biomarkers, sensor systems, and clinical translation12. Translational cardiometabolic biosensing integrating biomarkers, multiplex panels, sensing strategies, and clinical validation13. Multi-omic biomarkers, biosensing technologies, and precision diagnostics for rare and inherited metabolic disorders14. Advanced biophysical biosensing strategies for monitoring oxidative stress and inflammation in metabolic disordersSection V: Translational perspectives and future directions15. Translating smart biosensors for metabolic health: Regulatory pathways, ethical governance and commercialization strategy